Everolimus

• 产品号: Everolimus
• CAS号: 159351-69-6
• 分子式: C53H83NO14
• 分子量: 958.22442

产品别名

• 标题: Everolimus
• IUPAC标准名: (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28Z,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0^4,^9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
• IUPAC传统名: (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28Z,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0^4,^9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
• 别名: 42-O-(2-hydroxyethyl)rapamycin

产品登记号

• ATC码: L04AA18
• KEGG ID: D02714
• 维基百科标题: Everolimus
• Chemspider ID: 21106307
• CAS号: 159351-69-6
• 美国药典/FDA物质标识码: 9HW64Q8G6G
• CHEMBL: 1201755
• ATC码: L01XE10
• DrugBank ID: DB01590
• PubChem CID: 6442177

产品性质

• 给药途径: Oral
• 半衰期: ~30 hours
• 法定药品分级: Rx-only
• 美国（FDA）药品许可证: Everolimus
• 妊娠期药物分类: D (US)